KDM1A and cancer: Overall, LSD1 inhibition attenuates the immunosuppressive phenotype, which is critical in “cold tumors” such as OSCC, highlighting a specific dual mechanism by which LSD1 inhibition attenuates cancer cell division and promotes the immune response network.